Nippon India Pharma Fund-Growth Plan-Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 559.5402 ↓ -1.62%
[as on 22 July, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option and its peers as on 22 July, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund-Growth Plan-Growth Option 9.89% -1.62% -1.15% 2.25% 10.59% 7.72% 19.16% 12.22% 21.74% 14.77%
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 20.87% 0.37% 1.42% 6.76% 18.22% 16.15% 23.48% 16.8% 24.82% 13.55%
SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth -3.84% -0.95% -0.49% 0.14% -0.1% -0.95% 9.61% 9.77% 12.56% 11.41%
SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH 3.28% -0.99% -0.19% -1.5% 1.72% 1.29% 16.61% 17.53% 19.03% 14.75%
SBI PSU Fund - REGULAR PLAN -Growth 1.21% -0.5% -0.13% -3.31% -6.1% 6.87% 24.12% 23.1% 18.76% 13.95%
SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH -6.12% -0.52% 0.34% 0.43% -2.85% -7.83% 6.69% 12.69% 15.35% 12.95%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns -10.27% 7.14% 3.79% 2.14% 67.04% 22.66% -10% 40.12% 34.25% -3.81%

Discrete returns (monthly)

MonthSep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026
Returns -2.59% 2.16% 0.82% -1.31% -4.73% 5.23% -4.93% 5.96% 2.29% 5.39%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 13.19% 4%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.45% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.55%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology13.92%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology8.45%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology6.41%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology5.96%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology5.42%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.15%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing3.86%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology3.36%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services3.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services3.15%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology3.15%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.87%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology2.81%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology2.77%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.64%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.43%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.17%
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology2.09%
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.02%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services1.94%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.90%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology1.72%
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services1.67%
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology1.51%
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology1.16%
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.12%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.11%
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology0.94%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.93%
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology0.89%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.88%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.67%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.62%
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.38%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.14%
Portfolio data is as on date 31 March, 2026

NAV history

Nippon India Pharma Fund-Growth Plan-Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
22 July, 2026559.5402 -1.62%
21 July, 2026568.7785 0.34%
20 July, 2026566.8426 1.05%
17 July, 2026560.9581 -1.13%
16 July, 2026567.3540 0.23%
15 July, 2026566.0639 0.26%
14 July, 2026564.5981 0.64%
13 July, 2026561.0211 -0.23%
10 July, 2026562.2939 0.34%
9 July, 2026560.3771 0.88%
8 July, 2026555.4759 -1.13%
7 July, 2026561.8106 -0.54%
6 July, 2026564.8352 0.11%
3 July, 2026564.2165 1.2%
2 July, 2026557.5002 0.44%
1 July, 2026555.0394 -0.43%
30 June, 2026557.4174 0.73%
29 June, 2026553.3837 0.47%
25 June, 2026550.8208 -0.19%
24 June, 2026551.8614 0.34%
23 June, 2026550.0091 0.51%
22 June, 2026547.2029 0.84%
19 June, 2026542.6632 0.59%
18 June, 2026539.4585 0.79%
17 June, 2026535.2471 -0.12%
16 June, 2026535.9067 -0.07%
15 June, 2026536.2874 -0.42%
12 June, 2026538.5606 0.5%
11 June, 2026535.8811 0.21%
10 June, 2026534.7805

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The latest NAV of Nippon India Pharma Fund-Growth Plan-Growth Option is 559.5402 as on 22 July, 2026.
  • What are YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 9.89% as on 22 July, 2026.
  • What are 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 7.72% as on 22 July, 2026.
  • What are 3 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 19.16% as on 22 July, 2026.
  • What are 5 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 12.22% as on 22 July, 2026.
  • What are 10 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 12.22% as on 22 July, 2026.